Small airway dysfunction as predictor and marker for clinical response to biological therapy in severe eosinophilic asthma: a longitudinal observational study

BACKGROUND: Anti-T2 biological therapies have proven to effectively reduce acute exacerbations and daily doses of oral steroids in severe eosinophilic asthma. Despite the remarkable clinical efficacy, there are usually only moderate improvements in airflow limitation, suggesting that other measures...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Respir Res
Huvudupphovsmän: Abdo, Mustafa, Watz, Henrik, Veith, Vera, Kirsten, Anne-Marie, Biller, Heike, Pedersen, Frauke, von Mutius, Erika, Kopp, Matthias V., Hansen, Gesine, Waschki, Benjamin, Rabe, Klaus F., Trinkmann, Frederik, Bahmer, Thomas
Materialtyp: Artigo
Språk:Inglês
Publicerad: BioMed Central 2020
Ämnen:
Letter to the Editor
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC7579879/
https://ncbi.nlm.nih.gov/pubmed/33087134
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12931-020-01543-5
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk